Related Experiment Video
Updated: Aug 15, 2025

08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
7.6K
A protocol for establishing a male G×E schizophrenia mouse model
Tianyi Zhang1, Shangjin Li1, Fan Mei2
1School of Pharmaceutical Sciences, IDG/McGovern Institute for Brain Research, Tsinghua-Peking Joint Center for Life Sciences, Tsinghua University, Room B303, Beijing 100084, China.
STAR Protocols
|January 3, 2023
Summary
This study introduces a novel rodent model for schizophrenia, combining genetic BDNF deficiency with environmental stressors like hypoxia and social isolation. This model aims to improve schizophrenia research and drug development.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Schizophrenia pathogenesis is influenced by gene-environment interactions (G×E).
- Existing models may not fully capture the complexity of schizophrenia etiology.
- BDNF gene variations are implicated in schizophrenia risk.
Purpose of the Study:
- To present a protocol for a novel rodent model of schizophrenia.
- To establish a specific genetic and environmental factor (G×E) pair for schizophrenia research.
- To facilitate basic research and drug development for schizophrenia.
Main Methods:
- Breeding of Bdnf-e6-/- mice with a deficiency in promoter-VI-driven BDNF expression.
- Exposure of mice to postnatal environmental stressors: hypoxia, social isolation, and corticosterone.
- Detailed protocol for creating a G×E schizophrenia rodent model.
Main Results:
- Successful generation of a rodent model incorporating specific G×E factors relevant to schizophrenia.
- The model integrates genetic predisposition (Bdnf deficiency) with environmental triggers.
- The protocol provides a reproducible method for schizophrenia modeling.
Conclusions:
- The developed rodent model offers a more accurate representation of schizophrenia etiology.
- This model can serve as a valuable tool for investigating schizophrenia pathogenesis.
- It may accelerate the discovery and development of novel therapeutic strategies for schizophrenia.

